Citigroup

Citigroup’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Citigroup’s Portfolio PRVL Stock Details PRVL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$92K	Buy
2020 Q3	$27K	Sell
2020 Q2	$60K	Sell
2020 Q1	$81K	Buy
2019 Q4	$65K	Buy
2019 Q3	$5K	Buy